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Abstract 
 
Fatigue-induced microdamage in bone contributes to stress and fragility fractures and 
acts as a stimulus for bone remodelling.  Detecting such microdamage is difficult as 
pre-existing microdamage sustained in vivo must be differentiated from artefactual 
damage incurred during specimen preparation.  This was addressed by bulk staining 
specimens in alcohol soluble basic fuchsin dye, but cutting and grinding them in an 
aqueous medium.  Nonetheless, some artefactual cracks are partially stained and 
careful observation under transmitted light, or epifluorescence microscopy, is 
required.  Fuchsin lodges in cracks, but is not site-specific.  Cracks are discontinuities 
in the calcium-rich bone matrix and chelating agents, which bind calcium, can 
selectively label them.  Oxytetracycline, alizarin complexone, calcein, calcein blue 
and xylenol orange all selectively bind microcracks and, as they fluoresce at different 
wavelengths and colours, can be used in sequence to label microcrack growth.  New 
agents which only fluoresce when involved in a chelate are currently being developed 
– fluorescent photoinduced electron transfer (PET) sensors.  Such agents enable 
microdamage to be quantified and crack growth to be measured and are useful 
histological tools in providing data for modelling the material behaviour of bone.  
However, a non-invasive method is needed to measure microdamage in patients.  
Micro-CT is being studied and initial work with iodine dyes linked to a chelating 
group has shown some promise.  In the long term, it is hoped that repeated 
measurements can be made at critical sites and microdamage accumulation 
monitored.  Quantification of microdamage, together with bone mass measurements, 
will help in predicting and preventing bone fracture failure in patients with 
osteoporosis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 INTRODUCTION 
Microdamage in bone acts a stimulus for bone remodelling, initiating resorption by 
osteoclasts and new bone formation by osteoblasts (Frost, 1973; Martin & Burr, 1989; 
Mori & Burr, 1993; Bentolila et a. 1998; Verborgt et al. 2000; Lee et al. 2002).  The 
balance between damage creation and repair is an important one and can be upset by 
increased damage creation or deficient repair.  In athletes and military recruits, 
increased rates and magnitudes of loading lead to microdamage accumulation and 
stress fractures (Meurman & Elfving, 1980; Matheson et al. 1985; Daffner & Pavlov, 
1992).  Deficient repair causes microdamage to accumulate in the elderly (Schaffler et 
al. 1995; Norman &Wang, 1997; Zioupos, 2001) which, together with loss of bone 
mass, contributes to fragility fractures associated with minor trauma (Heaney, 1993).  
Of these, hip fractures are associated with the greatest morbidity and up to 20% 
mortality within 6 months (Riggs & Melton, 1995).  Demographic trends suggest that 
hip fracture incidence worldwide will increase from 1.7 million in 1990 to 6.3 million 
by 2050 (Melton, 1996). 
 
DETECTION 
A wide range of methods have been used to detect microdamage in bone.  Morris & 
Blickenstaff (1967) noted transverse lesions on the tensile surface of the tibia on X-
Ray while Chamay & Tschantz (1972) found “plastic slip lines” in overloaded ulnae 
using scanning electron microscopy.  Carter & Hayes (1977) demonstrated the 
difference in damage patterns on compressive and tensile surfaces using reflected 
light photomicrography.  In 1994, Zioupos et al. confirmed acoustic-emission as a 
method of microcrack detection and Raman spectroscopic markers for fatigue-
induced microdamage have recently been identified (Timlin et al. 2000).  However, in 
practice such methodologies have been little used.  By far the most popular method of 
microcrack detection has been transmitted light microscopy, despite the risk of 
introducing artefactual damage during the cutting and grinding of thin sections.  
 
BASIC FUCHSIN 
This problem of artefactual damage was addressed by Frost (1960) who introduced a 
technique in which fresh bone was bulk-stained in basic fuchsin, an ethanol-soluble 
dye (6% @ 260C; Rost, 1995), for several weeks to enable it to penetrate cracks that 
has been generated in vivo (Fig. 1).  After this period, the bone was rehydrated and all 
subsequent processing carried out in an aqueous medium.  This achieved two things: 
firstly, as fuchsin is insoluble in water (0.26% @ 260C; Rost, 1995), it could not leach 
out and penetrate new defects caused by processing and secondly, hydrated bone is 
less brittle than bone in alcohol, which facilitates sectioning (Frost, 1960).  Burr et al. 
(1985) viewed such fuchsin-labelled features under both transmitted light and, 
following sputter coating with gold, scanning electron microscopy and confirmed that 
they were indeed microcracks. 
 This technique was successfully used by Forwood & Parker (1989) to detect 
microdamage in vitro, but Burr & Stafford (1990), in communication with Frost, 
identified a potential flaw in the process - could the cracks be artefactual, caused by 
shrinkage of bone due to dehydration in alcohol during the bulk-staining procedure?  
To answer this, they compared crack counts in human rib sections bulk-stained in 
fuchsin and alcohol with control sections cut and ground in water and fuchsin-stained 
after mounting on slides.  No difference was found in the total crack counts for each 
group and thus the fuchsin method was validated. 
 
Burr & Stafford (1990) also modified Frost’s (1960) criteria for identifying cracks – 
Table 1.  This modified process was successfully used to detect microcracks 
generated both in vitro (Akhter et al. 1993) and in vivo (Mori & Burr, 1993).  Using 
the fuchsin method, the numeric crack densities in human rib reported by Frost (1960) 
and by Burr & Stafford (1990) were similar and these data provide a bench-mark for 
the comparison of detection methods.  This benchmark was used by Schaffler et al 
(1994) to test the efficacy of a lead-uranyl acetate stain for detecting microcracks 
using both light and electron microscopy. 
 
One problem remained, however.  The cutting and grinding processes produce a 
plethora of scratches and cracks which appear black in colour under transmitted light.  
Variation of the light intensity reveals that some of these are true microcracks, the 
thick plug of fuchsin appearing black in low and purple at high light intensities, with a 
fuchsin halo in the surrounding bone.  Others are preparation artefacts, either cracks 
unstained by fuchsin or containing some dye and debris from the grinding process.  
By varying light intensity, depth of focus and magnification, pre-existing microcracks 
that had been generated in vivo could be differentiated from artefactual damage, but 
the procedure was both difficult and time-consuming (Burr & Stafford, 1990). 
 
Fuchsin fluorescence 
Fluorochromes are substances which absorb energy in the form of light which causes 
electrons to move into higher energy shells away from the nucleus.  When these 
electrons return to more stable, lower energy shells the energy is dissipated as both 
heat and light.  Because the emitted photon has less energy than the excitation photon, 
the wavelength of the emission is longer by Stokes’ Law, and the difference between 
the wavelengths of the excitation and emission maxima is known as the Stokes’ Shift 
(Rost, 1995).  In epifluorescence microscopy an excitation filter selectively transmits 
light at the excitation maximum to strike the fluorochrome and, en route to the 
eyepiece, a barrier filter blocks this wavelength while transmitting as much as 
possible of the fluorescence emission.   
 
Basic fuchsin is both a diachrome, as it appears coloured under transmitted light, and 
a fluorochrome. It is a mixture of three triarylmethane dyes: pararosanalin, rosanilin 
and Magenta II and the heterocyclic molecular structures are responsible for their 
fluorescence properties.  They provide a large conjugated system in which electrons, 
less strongly bound than σ electrons, can be promoted to the π antibonding orbitals by 
absorption of photon energy without excessive disruption of bonding (Rost, 1992).  
As these electrons return to more stable orbitals, basic fuchsin fluoresces.  Maximal 
absorption of light occurs at a wavelength of 545 nm (Rahn, 1977; Rost, 1995), which 
is in the green area of the spectrum. Excited by an incident light of this wavelength, 
fuchsin emits light of a longer wavelength which appears orange when viewed with a 
red barrier filter. 
 
Lee et al. (1998) examined in vivo microcracks in human rib using both transmitted 
light and epifluorescence microscopy at x 125 magnification.  They found no 
differences in crack number, density or crack length between the two methods, 
indicating comparable accuracy.  However, using green incident light (545 nm), only 
microcracks containing fuchsin fluoresced orange against the darkfield background 
(Fig. 2) and so unstained, artefactual cracks could be screened out. Under UV 
epifluorescence, microcracks stained through the full 100 µm depth of the section 
fluoresced purple, while partially stained cracks failed to fluoresce and were screened 
out.  Thus epifluorescence microscopy provided a rapid screening method for 
differentiating microcracks fully-stained with fuchsin from partially or unstained  
artefactual microdamage.  Huja et al. (1999) used transmitted light and the 
fluorescence-aided method to study in vitro microdamage in bovine specimens 
subjected to four-point cyclic bending and around endosseous implants.  Using 
thinner sections (80 µm) at a higher magnification (x 150), they found that 
significantly more microdamage was detected using fluorescence and noted a trend 
towards higher intraobserver repeatability. 
 
LASER SCANNING CONFOCAL MICROSCOPY   
In laser scanning confocal microscopy (LSCM), the laser light source is tuned to the 
excitation and emission characteristics of the fluorescent dye, background emissions 
can be eliminated and high spatial resolution can be achieved (Boyde et al. 1994; 
Zioupos & Currey, 1994).  Using this technique, Zioupos (2001) was able to identify 
microcracks labelled with fluoroscein, measure them to an accuracy of approximately 
10 µm and correlate microcrack parameters with material properties, notably 
toughness.  Reilly & Currey (2000) used a similar technique to compare the 
appearance and material properties of specimens loaded in tension and compression.  
The laser can be focussed at a defined depth within a specimen and using its scanning 
mode, a thin optical section of the specimen can be taken. By scanning the laser at 
different depths through the entire depth of a section to generate a series of individual 
slices at specific intervals, and then combining them using computer reconstruction, 
the three dimensional shapes of microcracks can be seen.  O’Brien et al. (2000) 
performed this in fuchsin-stained human rib sections and found that their elliptical 
microcracks were comparable to reconstructions from serial histological sections and 
theoretical predictions (Taylor & Lee, 1998). 
 
SITE SPECIFICITY   
There are two major problems with fuchsin as a stain – the first is that it is a single 
agent, whereas a series of dyes would be required to study microcrack growth.  Basic 
fuchsin has been used in sequence with toluidine blue, but differentiation between the 
two dyes was poor (Vashishth et al. 1994).  The second problem with fuchsin 
concerns its site-specificity. Basic fuchsin collects in voids in bone, from vascular 
channels to canaliculi.  Microcracks are, in part, identified by their intermediate size 
(Burr & Stafford, 1990), although more diffuse staining has been reported (Schaffler 
et al. 1996).  This poses the question: does fuchsin merely act as a space-occupying-
lesion, diffusing into gaps in the tissue and crystallising there or does it specifically 
bind to microcracks?  In order to answer this, we must first consider the nature of the 
feature to be identified and ask - what is a bone microcrack? 
 
What is a bone microcrack? 
Landis (1995) described the mineralisation process in bone.  Nucleation of mineral 
occurs in the “hole” regions of the collagen arrays and hydroxyapatite crystals,  
Ca10(PO4)6(OH)2, develop in length along the collagen long axes and in width along 
channels within the collagen sheets. In such a two-phase structure, a microcrack 
would most likely be a break or fissure in the hydroxyapatite matrix, exposing new 
surfaces.  This would involve the cleaving of bonds between constituent atoms 
leaving charged ions exposed on the surfaces of the microcrack and, in 1 µm3 of 
compact bone, 55% of the ions present are Ca2+.   In order to be site-specific, the two 
major constituents of basic fuchsin, rosanilin and pararosanilin, should be capable of 
binding strongly and selectively with ions lining the walls of microcracks.  The most 
stable configuration would be a chelate ring, but the absence of NH2 groups close 
together prevents this.  Furthermore, the ions present in bone, Ca2+, Na+ and Mg2+, 
are considered to be “hard” metal ions and have little affinity for nitrogen donor 
atoms which are relatively “soft” (Huheey, 1983).  An  NH2 group from either dye, 
acting as a monodentate donor, could form a relatively weak bond with a metal ion or 
they may interact weakly by hydrogen bonding with oxygen atoms in calcium 
carbonate or phosphate.   However, basic fuchsin can bind with proteins such as 
elastin (Pihlman & Linder, 1983) and collagen (Joiner et al. 1968).  Collagen 
comprises 30% of bone by weight, as compared with 60% for the hydroxyapatite 
matrix.  Microcracks occurring in hydroxyapatite which is laid down around and 
between collagen fibrils, might be expected to have some collagen exposed along 
their walls.  Thus it is likely that fuchsin labels such microcracks in part by binding to 
exposed collagen and in part as a space-occupying agent, diffusing into the crack and 
lodging there. 
 
An ideal marker for microdamage in bone would be both site-specific and easily 
detected.   An agent with two adjacent donor sites capable of forming a strong ring or 
chelate with calcium ions lining the crack walls would be site-specific.  The presence 
of fluorescence properties would aid detection.  A chelating fluorochrome fulfils both 
criteria. 
 
Fluorochromes 
In the 1770s, John Hunter used madder dye to show that bone is subject to both 
deposition and resorption (Hall, 1992).  The most important madder dye is alizarin, 
but it has been superseded as a bone label by the tetracycline family of antibiotics 
which share its calcium chelation and fluorescence properties but whose chemical 
behaviour is better understood.  Chlortetracycline was introduced in 1948, followed 
by oxytetracycline in 1950 and the nomenclature parent of the series, tetracycline, in 
1953 (Boothe & Hlavka, 1985).  All are fermentation products of Streptomyces 
bacteria and share a common nucleus (Blackwood, 1985).  The tetracyclines are 
strong chelating agents, able to sequester a metallic ion such as calcium and firmly 
bind it into a ring.  The primary site for chelation was first assigned as the 11,12-beta-
diketone system.  In organic compounds, fluorescence is restricted to those possessing 
a large conjugated system in which electrons can be promoted to antibonding orbitals 
without excessive disruption of bonding.  The heterocyclic structure of the 
tetracyclines fulfils this requirement.  Tetracycline is maximally excited by ultraviolet 
light of wavelength 390 nm and emits maximal yellow fluorescence of wavelength 
515 nm (Rost, 1995).  
 
In vivo  labelling 
Andre (1956) found that intravenous tetracycline concentrated in bone in mice.  Milch 
et al. (1957) reported the administration of tetracycline, chlortetracycline and 
oxytetracycline to several species of laboratory animals.  Almost instantaneously after 
intravenous administration, and within 30 minutes of intraperitoneal injection, yellow-
gold fluorescence was induced by ultraviolet light in soft tissues, with the exception 
of the brain.  This disappeared from soft tissues within six hours, but persisted in 
bone.  Subsequent experimental evidence revealed that tetracycline is deposited where 
bone or cartilage matrix is mineralising and its pattern is the same as that of 
radiolabelled calcium deposition (Frost et al. 1961).  In a series of papers Frost (1961, 
1963a,b, 1966a,b, 1969, 1973) developed a method for in vivo labelling of bone 
formation using sequential tetracycline labels.  Intermittent administration resulted in 
a series of bands in the mineralised bone enabling the rate of new bone deposition to 
be measured: 1.5 µm/day in young children declining to 0.72 µm/day in the seventh 
and eighth decades (Frost, 1969).  Using iliac crest biopsies, these techniques have 
been applied to the analysis of bone modelling and remodelling dynamics and to the 
diagnosis of mineralisation disorders such as rickets and osteomalacia (Recker, 1993). 
 
However, owing to the similarity in colours of the tetracycline family, ranging from 
yellow to green, differentiation between the labelled bands was problematic.  Harris 
(1960) introduced a two colour technique, combining tetracycline with alizarin red, 
which could easily be differentiated under both transmitted white light and 
epifluorescence.  Suzuki & Matthews (1966) combined tetracycline and a green 
calcein derivative and subsequently Modis et al. (1969) combined all three dyes.  In 
the early 1970s, Rahn & Perren introduced calcein blue (1970), xylenol orange (1971) 
and, based on the original madder dye, alizarin complexone (1972).  All possess 
adjacent donor sites for calcium chelation and all are fluorochromes.   
 
Simultaneous excitation and visualisation of all these agents from blue to red, requires 
excitation in the ultraviolet range and an almost colourless barrier filter.  This may be 
far from the optimum for an individual fluorochrome, but this can be compensated by 
increasing its dosage so that all colours appear equally bright under the microscope.  
Rahn (1977) developed a dosage and sequence regime for fluorochrome 
administration to facilitate interpretation of the histological image (Table 2) which has 
been used, with minor modifications, to label bone remodelling under conditions of 
altered mechanical load (Lanyon et al. 1982; Burr et al. 1989; Lee et al. 2002) (Fig.3).   
 
When an animal was sacrificed immediately after the administration of the label, 
fluorescence has also been observed in the demineralising bone of resorption lacunae 
(Harris et al. 1962; Olerud & Lorenzi, 1970; Lee et al. 1999).  However, when three 
days elapsed between administration of the label and sacrifice, the label was not found 
at such resorption sites (Treharne & Brighton, 1979), indicating that  bone resorption 
is a rapid process, estimated at 50 µm/day longitudinally and 5 µm/day radially  in 
cortical bone (Martin & Burr, 1989).  
 
There is only one report of fluorescent labelling of microcracks in vivo. Stover et al 
(1993) trained race horses until they developed dorsal metacarpal disease, also known 
as “bucked shins” or stress fractures.  Calcein was given intravenously, at a dosage of 
15 mg/kg, prior to euthanasia.  Two 1 cm thick specimen were taken in the transverse 
plane from the dorsal aspect of the third metacarpal.  One specimen was bulk-stained 
with fuchsin by the method of Burr and Stafford (1990), 100 µm sections made and 
fuchsin-stained microcracks observed.  The second specimen was also cut into 100 
µm sections and examined using scanning electron microscopy.  The microcracks 
seen by this method were found to contain calcein label when viewed using 
epifluorescence microscopy.   This supports the earlier theoretical proposal that 
microcracking involves the exposure of calcium ions which can be chelated by a 
fluorescent label.  
 In vitro  labelling 
Buyske et al. (1960) reported that a freshly-excised rat femur, immersed for one 
minute in a solution containing tetracycline, was capable of fluorescence even after 
washing with distilled water.  Steendijk (1964) put rib sections, stored in formalin for 
a week, and tribasic calcium phosphate into tetracycline solution.  Both specimens 
took up the label and he concluded “that the tetracyclines are fixed to bone salt by a 
nonvital mechanism and that this is mediated by a process of adsorption” (Steendijk, 
1964).  Tapp et al. (1965), having stained ground, undecalcified sections of rat bone, 
concluded that “the staining of tissues in vitro with tetracycline is very similar to that 
found after the administration of tetracycline to animals in vivo”. 
 
Given this similarity and the difficulty of differentiating between sequential labels 
from the tetracycline family, Aaron et al. (1984) administered a tetracycline to 
patients in vivo and the second label in the sequence to their iliac crest biopsies in 
vitro, using a variety of toxic agents such as alizarin red and xylenol orange.  They 
found that the calcification front was labelled in a similar manner to that in in vivo 
studies and noted also that some resorption cavities and mineralised regions damaged 
by the trephine fluoresced with tetracycline stain (Aaron et al. 1984).   
 
This raised the question as to whether this group of calcium binding fluorochromes 
could be used to label microdamage in vitro.  Lee et al. (2000a) randomly assigned 
human rib sections for bulk staining in 1% solutions of alizarin complexone, calcein, 
calcein blue, oxytetracycline, xylenol orange and basic fuchsin.  Microcracks were 
observed with all 6 stains (Fig. 4) but neither crack density nor length differed 
between them.  They then applied the dyes in sequence to bovine trabecular bone 
specimens undergoing cyclic fatigue testing in compression.  Specimens were 
immersed in oxytetracycline for 16 hours under vacuum, rinsed with distilled water 
and then fatigue tested.  Oxytetracycline labelled pre-existing damage while new 
microcracks and microfractures were unstained enabling test-induced damage to be 
quantified.  Other specimens were immersed in calcein blue for the first 75% and in 
xylenol orange for the final 25% of the test.  Some microcracks were stained blue 
indicating that they were formed during the first 75% of the test, some with both dyes 
indicating crack growth and some with xylenol orange only indicating that they were 
formed in the final quarter of the fatigue test.  However, the transition from one dye to 
another was imprecise and, at the machined edges, there was evidence of dyes 
‘painting over’ or substituting one another.   
 
O’Brien et al. (2002) addressed these problems by using ion chromatography to 
measure the affinity of each fluorochrome for free calcium.  The agents were then 
applied in decreasing order of affinity to bone specimens which had been scratched to 
mimic surface cracks and the fluorochrome concentrations were varied to obtain the 
optimal labelling protocol – alizarin complexone, xylenol orange, calcein (each at 
0.0005 M) and calcein blue (0.0001 M).  This was then successfully used to label 
microcrack accumulation at intervals during fatigue testing of compact bone (O’Brien 
et al. 2003) (Fig.5). 
 
PHOTOINDUCED ELECTRON TRANSFER 
Agents that modulate fluorescent Photoinduced Electron Transfer (PET) exhibit 
reversible ‘off-on’ switching of fluorescence upon ion recognition (de Silva et al. 
1997a). PET sensors are based upon the use of a fluorophore-spacer-receptor format, 
where binding of an ion (the guest) is at the receptor site. The presence of this guest is 
then signaled by the changes in the emission intensity (quantum yield) of the 
fluorophore (de Silva et al. 1997b). Gunnlaugsson et al. (2003a) have designed 
sensors for various ions based on this principle. Before ion binding, the fluorophore is 
‘switched off’ due to quenching of its excited state by electron transfer from the 
receptor.  Once the receptor forms a chelate, electron transfer and concomitant 
quenching is stopped and fluorophore emission is ‘switched on’.  Such agents show 
promise for labeling microdamage sites and identifying specific cations in tissue 
(Gunnlaugsson et al. 2003a,b).  
 
NON-INVASIVE IMAGING 
Histological assessment of microdamage requires sectioning of bone and thus 
destruction of the specimen.  A non-invasive imaging technique would avoid such 
destructive processing and offer an opportunity to quantify microdamage at intervals 
and so measure its accumulation over time.  It also offers the prospect of measuring 
microdamage in patients.   Site-specificity can be achieved as before using a receptor 
to bind exposed calcium in microcrack walls, while iodine atoms are detectable using 
CT scanning.  Iodinated contrast agents are used in about 20 million procedures 
annually in the US.  An iodine derivative with a receptor site for ions such as calcium, 
and thus high affinity for microcracks, has been developed (Fig. 6).  Initial studies of 
scratched bone specimens using micro-CT have demonstrated proof of principle (Fig. 
7). 
 
CONCLUSIONS 
Microdamage has been identified in the aged human femur (Boyde, 2002) and its 
accumulation contributes to fragility fractures (Schaffler et al. 1995; Norman &Wang, 
1997; Zioupos, 2001).  Detection methods have been used to show different patterns 
of microcracking on compressive and tensile surfaces (Chamay, 1970; Fyhrie & 
Schaffler, 1994; Wachtel & Keaveny, 1995).  Mechanical testing of bone specimens 
has been used to relate microcrack growth to changes in material properties in both  
static and fatigue loading (Carter & Hayes, 1976, 1977; Schaffler et al. 1990; Zioupos 
et al. 1996; Lee et al. 2000b; O’Brien et al. 2003).  Based on such data, models of 
bone behaviour have been developed and applied to prediction of fracture and implant 
loosening (Carter& Caler, 1985; Prendergast & Taylor, 1994; Martin, 1995, 2002; 
Taylor and Kuiper, 2001; Taylor and Lee, 2003).  
 
Clinically however, fracture risk assessment is based mainly on bone quantity, 
measured as density, yet density accounts for only 60-70% of the variance in elastic 
modulus (stiffness) and strength of bone (Goldstein, 1987; Rice et al. 1988). Bone 
failure, like heart or renal failure, is a complex multifactorial disease (Ott, 1993).  The 
inclusion of bone quality measures, including microdamage, will improve risk 
assessment and thus fracture prevention (Sherman & Hadley, 1993).  In 2000, the 
European Society of Biomechanics identified the development of a clinical method to 
quantify bone microdamage as a research priority, but as the one with the least 
feasibility of solution (Prendergast & McCormack, 2002).  In 2003, we can show 
some evidence of progress, but there is still much to do. 
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Table 1. Criteria for identifying microcracks (after Burr and Stafford, 1990) 
                  
 
1.  They are intermediate in size, larger than canaliculi but smaller than 
 vascular channels. 
 
2.  They  have sharp borders with a halo of basic fuchsin staining around them. 
 
3.  They are stained through the depth of the section. 
 
4. When the depth of focus is changed, the edges of the crack can be observed 
 to be more deeply stained than the intervening space. 
                   
 
 
Table 2.  Excitation and emission maxima of chelating fluorochromes and their recommended 
  sequence and dosages for in vivo administration (after Rahn, 1977; Rost, 1995)  
            
Fluorochrome  Excitation  Emission Colour  Dosage 
   wavelength  wavelength    (intravenous)  
Calcein blue  375 nm 435 nm blue  30 mg/kg 
  
Xylenol orange 377 nm 615 nm orange  90 mg/kg 
 
Calcein  495 nm 540 nm green  10 mg/kg 
 
Alizarin  
complexone  580 nm 625 nm red  30 mg/kg 
 
Oxytetracycline 390 nm 520 nm yellow  30 mg/kg 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1: Fuchsin stained microcrack.  Bar = 50 µm 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2: Fuchsin stained microcrack viewed using green epifluorescence (546 nm). Bar 
= 50 µm 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3: Periosteal fibrolamellar bone formation sequentially labelled with chelating 
fluorochromes: oxytetracycline (yellow), alizarin complexone (red) and calcein 
(green).  UV epifluorescence, 365 nm, Bar = 100 µm 
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Fig. 4: Microcracks labelled with (a) calcein blue (UV epifluorescence, 365 nm), (b) 
alizarin complexone (green epifluorescence, 546 nm) and (c) oxytetracycline (UV 
epifluorescence, 365 nm). Bar = 50 µm 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5: Fracture surface sequentially labelled with alizarin complexone (red), calcein 
(green) and oxytetracycline (yellow). UV epifluorescence, 365 nm, Bar = 100 µm 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
Fig. 6: Three - iodinated contrast agent with one binding site  
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Fig. 7: MicroCT of bone specimen of cross-section 2 mm x 2mm.  Scratch labelled 
with iodinated contrast agent shown in Fig. 6. 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
